Maravai Lifesciences Holdings (MRVI) Total Liabilities (2020 - 2026)

Maravai Lifesciences Holdings' Total Liabilities history runs 7 years deep, the most recent figure standing at $344.1 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 19.87% year-over-year to $344.1 million; the TTM figure through Mar 2026 stood at $344.1 million (down 19.87% YoY), while the FY2025 annual figure was $397.9 million, down 7.7% from the prior year.
• Total Liabilities was $344.1 million for Q1 2026 at Maravai Lifesciences Holdings, down from $397.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.4 billion in Q1 2023 to a low of $344.1 million in Q1 2026.
• Historically, Total Liabilities has averaged $875.2 million across 5 years, with a median of $671.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities rose 21.62% in 2022, then tumbled 52.84% in 2024.
• A 5-year view of Total Liabilities shows it stood at $1.4 billion in 2022, then sank by 49.34% to $697.6 million in 2023, then sank by 38.21% to $431.0 million in 2024, then retreated by 7.7% to $397.9 million in 2025, then decreased by 13.51% to $344.1 million in 2026.
• The last three Total Liabilities figures came in at $344.1 million (Q1 2026), $397.9 million (Q4 2025), and $417.3 million (Q3 2025), per Business Quant data.